微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 0.4% | 102.95% | 113.33% | 110/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -3% | 46.81% | 13.29% | 131/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -3.46% | -2406.67% | 93.3% | 136/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -51.66% | -18550% | -280.69% | 146/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -13.57% | -722.48% | -140.6% | 138/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -5.64% | -380.6% | -3860% | 129/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.15% | -84.38% | -46.43% | 116/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 0.28% | -96.32% | -87.16% | 110/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 2.18% | -68.95% | 8.46% | 95/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.01% | -61.49% | 109.38% | 86/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.96% | -59.66% | -87.37% | 93/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 7.6% | -14.99% | 8.26% | 61/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 7.02% | -3.31% | 34.48% | 62/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.22% | 11.54% | 119.33% | 54/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.38% | 33.71% | -73.38% | 58/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 8.94% | 8.1% | 23.14% | 65/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 7.26% | -2.68% | 55.13% | 56/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 4.68% | 3.08% | 162.92% | 59/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.78% | -20.18% | -78.48% | 54/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 8.27% | 49.01% | 10.86% | 69/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 7.46% | 12.01% | 64.32% | 49/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 4.54% | 5.09% | 103.59% | 55/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.23% | 17.37% | -59.82% | 53/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 5.55% | -33.05% | -16.67% | 82/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 6.66% | 14.83% | 54.17% | 50/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.32% | 18.68% | 127.37% | 51/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.9% | -0.52% | -77.08% | 58/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 8.29% | -10.86% | 42.93% | 62/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 5.8% | -10.36% | 59.34% | 60/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 3.64% | -14.75% | 90.58% | 67/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.91% | 1.06% | -79.46% | 45/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 9.3% | -8.46% | 43.74% | 62/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 6.47% | 17% | 51.52% | 41/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 4.27% | 11.2% | 125.93% | 44/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.89% | 23.53% | -81.4% | 41/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 10.16% | 6.28% | 83.73% | 50/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 5.53% | 0% | 44.01% | 45/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 3.84% | -8.13% | 150.98% | 48/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 1.53% | -13.07% | -84% | 46/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |